Study at a glance
What question did the studies ask?
Does vitamin D change diabetes, infections, autoimmune disease or fractures in adults? Autoimmune disease means the immune system attacks the body’s own tissues. Trials mainly involved middle-aged or older people. Some had blood sugar above normal but below the diabetes threshold. Treatments included vitamin D3 and, in one trial, an active vitamin D-like drug.
What did they find?
A combined analysis found a modest reduction in progression to diabetes, although the main comparisons in the individual diabetes trials were uncertain. Other trials did not demonstrate fewer respiratory infections or fractures with vitamin D alone. Later confirmation of autoimmune cases weakened an earlier positive estimate.
What does this mean?
The answer depends on the outcome and who was studied. A higher vitamin D blood result does not prove better health in every system. An uncertain trial result also does not mean vitamin D has no normal role.
What are the limits?
Young adults and some severely deficient groups were less well represented. Trials differed in treatments and other supplements. Some reported harms. One report available only as an abstract described more deaths; its full paper could not be assessed. These findings do not establish a personal dose or blood target.
Read the full article below ↓This review asks whether vitamin D changes meaningful adult outcomes, including diabetes, infections, autoimmune disease and fractures. Autoimmune diseases are conditions in which the immune system attacks the body’s own tissues. It compares clinical trials rather than assuming a higher vitamin D blood result means better health in every system. Read the detailed assessment, Vitamin D and Adult Functional Outcomes: Full Evidence Review.
What did the studies examine?
Participants were mainly middle-aged or older. Some had prediabetes, meaning blood sugar was above the normal range but below the diabetes threshold. Most large trials did not recruit only people with severe vitamin D deficiency.
Treatments differed. Vitamin D3 is a nutritional form. Eldecalcitol is an active vitamin D analogue, a drug with different handling in the body. One infection trial tested an offer of testing and supplementation rather than a comparison in which participants and researchers did not know which study pill was assigned.
What did they find?
The main planned comparisons in the individual D2d and DPVD diabetes trials did not show a clear benefit. A later analysis combining three trials found a modest reduction in progression to diabetes. That positive combined finding matters, but it does not establish a personal dose or blood target. For the metabolic background, see Vitamin D and Metabolism.
CORONAVIT did not demonstrate fewer respiratory infections. Many controls took vitamin D outside the trial, limiting the treatment comparison.
An early VITAL report suggested fewer autoimmune diseases. Later confirmation of cases weakened the estimate even for the original treatment period. The update cannot be explained only as benefit disappearing after treatment stopped. The detailed immune comparison is Vitamin D, Immune Tolerance Mechanisms and Autoimmune Outcomes: Full Evidence Review.
VITAL did not demonstrate fewer fractures with vitamin D alone. A smaller trial found a small improvement in calcium absorption in an analysis that accounted for starting differences without demonstrated improvements in the main bone, muscle or physical-function outcomes. Some trials combining calcium with vitamin D found fracture benefits, but those effects cannot be assigned to vitamin D alone.
A separate analysis used UK Biobank records to study infection patterns. It did not assign vitamin D treatment by chance. Its estimates depended on assumptions and could not prove that supplements prevented infections.
What does this mean?
Different outcomes give different answers. A change in a blood marker or laboratory test does not prove a clinical benefit. Equally, a trial without a clear benefit does not show that vitamin D has no normal role in the body. For the distinction between blood measurements and function, see Functional Vitamin D Status.
What are the limits?
Results depend on who was studied, the compound, other treatments and follow-up. Evidence in healthy young adults and some severely deficient groups is limited. Safety cannot be assumed: some studies reported adverse effects, and one trial report, available here only as an abstract, reported more deaths with vitamin D. The full report could not be assessed.
The review does not establish that everyone benefits, that nobody benefits, or that a research dose is suitable for an individual.
Sources
Related reading
Vitamin D and Adult Functional Outcomes: Full Evidence Review
Compare vitamin D trials on diabetes, infections, autoimmunity, fractures and physical function, including null findings and evidence limits.
Read more →Early detection of osteoporosis in adult children of patients with proximal femur fractures: a real-world screening study
This study evaluated whether adult children of affected patients represent a suitable target group for early screening.
Original paper ↗Read more →Prevalence of Low Serum Alkaline Phosphatase and Hypophosphatasia in Adult Patients with Atypical Femur Fractures
ALP values were compared with those of a control group of patients with prior proximal femoral fracture during antiresorptive treatment (n = 20).
Original paper ↗Read more →Vitamin D deficiency in adult fracture patients: prevalence and risk factors
This study aimed to determine the prevalence of and risk factors for vitamin D deficiency in non-operatively treated adult fracture patients.
Original paper ↗Read more →2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older
To establish European League Against Rheumatism (EULAR) points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older.
Original paper ↗Read more →Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults
Patient characteristics, fractures and potential influencing factors were investigated.
Original paper ↗Read more →FRAX-based national survey of osteoporotic fracture risk, related knowledge, and associated factors, among Egyptian adults aged 40 years and older, 2025
This national survey included 2,242 participants over 40 years old from different regions in Egypt, using a questionnaire with five parts, including the OKAT questionnaire and the online FRAX tool, which was filled out by an interviewer.
Original paper ↗Read more →The METS-IR is independently related to bone mineral density, FRAX score, and bone fracture among U.S. non-diabetic adults: a cross-sectional study based on NHANES
The purpose of this study was to investigate the association between the metabolic score for insulin resistance (METS-IR) and bone mineral density (BMD) in American non-diabetic adults.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Age-specific effects of weight-based body size on fracture risk in later life: a lifecourse Mendelian randomisation study
Musculoskeletal conditions, including fractures, can have severe and long-lasting consequences.
Original paper ↗Read more →Antipsychotic medication use and fracture: a case-control study
We aimed to determine whether antipsychotic use is associated with fracture risk in a population-based sample of adults living in the Barwon Statistical Division, south-eastern Australia.
Original paper ↗Read more →Association between antibiotics use and osteoporotic fracture risk: a nationally representative retrospective cohort study
This population-based retrospective cohort study aimed to estimate the association between antibiotic exposure and osteoporotic fracture risk.
Original paper ↗Read more →Association of osteoporosis and sarcopenia with fracture risk in transfusion-dependent thalassemia
Patients with transfusion-dependent thalassemia (TDT) have an increased risk of osteoporosis and fractures.
Original paper ↗Read more →Bone Fracture History in Women With First Episode or With Persistent Anorexia Nervosa
To investigate fractures history in women with first episode anorexia nervosa (AN) (FE‐AN: ≤ 3 years duration) and those with persistent AN (P‐AN: ≥ 7 years), compared to healthy controls (HC).
Original paper ↗Read more →Bone health and fracture risk in diabetes: A multicenter study
We assessed bone health in over 2500 adults with diabetes across Türkiye.
Original paper ↗Read more →Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence
Also, the trabecular bone score was considerably lower in ALC patients compared with CAA and control individuals.
Original paper ↗Read more →Effectiveness of an integrated hospital-community care pathway for fragility fractures’ secondary prevention: the PROMOTER-II study
Among 9186 participants (74.7% women), aged 78 years, 12.7% initiated an AFT, and half of them (6.3%) within 6 months after the index FF.
Original paper ↗Read more →Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe
We aimed to determine the prevalence of self-reported fracture (past or current), associated risk factors and disability, by HIV status in Zimbabwean children.
Original paper ↗Read more →Frequency of Osteoporosis-Related Fractures in the Kingdom of Bahrain
The main objective of this study was to conduct a retrospective cross-sectional study to investigate the prevalence of fragility fractures in adult Bahraini patients.
Original paper ↗Read more →Vitamin D Analogues and Fracture Risk in Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
We performed a systematic review and meta‐analysis of randomized controlled trials (RCTs) to evaluate the effect of VDRAs on fracture risk and bone mineral density (BMD) in adult patients with CKD.
Original paper ↗Read more →Vitamin D and Bone: Mineralisation, Cell Signalling and Fractures: Full Study
Compare bone mineralisation and cell-signalling experiments with VITAL fracture results, keeping doses, models and clinical limits distinct.
Read more →Original sources
Vitamin D Supplementation and Prevention of Type 2 Diabetes
Published in Pittas AG et al (2019).
Publication details
Vitamin D Supplementation and Prevention of Type 2 Diabetes. Pittas AG et al. 2019. The New England journal of medicine. Volume 381(6); pages/article 520-530. DOI: 10.1056/nejmoa1900906.
Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population
Published in Kawahara T et al (2022).
Publication details
Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. Kawahara T et al. 2022. BMJ (Clinical research ed.). Volume 377; pages/article e066222. DOI: 10.1136/bmj-2021-066222.
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials
Published in Pittas AG et al (2023).
Publication details
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Pittas AG et al. 2023. Annals of internal medicine. Volume 176(3); pages/article 355-363. DOI: 10.7326/m22-3018.
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults
Published in LeBoff MS et al (2022).
Publication details
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. LeBoff MS et al. 2022. The New England journal of medicine. Volume 387(4); pages/article 299-309. DOI: 10.1056/nejmoa2202106.
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
Published in Hahn J et al (2022).
Publication details
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. Hahn J et al. 2022. BMJ (Clinical research ed.). Volume 376; pages/article e066452. DOI: 10.1136/bmj-2021-066452.
Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial
Published in Costenbader KH et al (2024).
Publication details
Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial. Costenbader KH et al. 2024. Arthritis & rheumatology (Hoboken, N.J.). Volume 76(6); pages/article 973-983. DOI: 10.1002/art.42811.
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
Published in Jolliffe DA et al (2022).
Publication details
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). Jolliffe DA et al. 2022. BMJ (Clinical research ed.). Volume 378; pages/article e071230. DOI: 10.1136/bmj-2022-071230.
Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial
Published in Hansen KE et al (2015).
Publication details
Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial. Hansen KE et al. 2015. JAMA internal medicine. Volume 175(10); pages/article 1612-1621. DOI: 10.1001/jamainternmed.2015.3874.
Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis
Published in Massé O et al (2026).
Publication details
Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. Massé O et al. 2026. BMJ (Clinical research ed.). Volume 393; pages/article e088050. DOI: 10.1136/bmj-2025-088050.
Impact of Vitamin D Supplementation on Hospitalizations for Infection: Results of the D-Health Trial Revisited
Published in Wang Y et al (2026).
Publication details
Impact of Vitamin D Supplementation on Hospitalizations for Infection: Results of the D-Health Trial Revisited. Wang Y et al. 2026. Nutrients. Volume 18(14); pages/article 2276. DOI: 10.3390/nu18142276.
Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial
Published in Joseph P et al (2023).
Publication details
Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial. Joseph P et al. 2023. Nutrition, metabolism, and cardiovascular diseases : NMCD. Volume 33(2); pages/article 434-440. DOI: 10.1016/j.numecd.2022.11.001. Abstract-level background only; the complete principal paper was unavailable for appraisal.